Douglas J. MacNeil

10.3k citations

81 papers · 5.8k indexed · 3 hit papers · h-index 37

Endocrine and Autonomic Systems top 0.1%
Molecular Biology top 5%
Pharmacology top 0.5%
Nutrition and Dietetics top 0.5%
Cognitive Neuroscience top 2%

Co-authors: Tanya MacNeil Xiao-Ming Guan L. H. T. Van der Ploeg Hong Yu Prashant Trivedi Keith M. Gewain Winston J. Brill Carolyn L. Ruby
Topics: Regulation of Appetite and Obesity (31 papers)Neuropeptides and Animal Physiology (22 papers)Receptor Mechanisms and Signaling (16 papers)
Cited by: Endocrine and Autonomic Systems Nutrition and Dietetics Pharmacology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Biotechnology
Partner nations: United States Japan Netherlands

In The Last Decade

Douglas J. MacNeil

81 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution of orexin receptor mRNA in the rat brain

1998 831 citations Douglas J. MacNeil et al. FEBS Letters profile →
Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector

1992 635 citations Douglas J. MacNeil, Keith M. Gewain et al. profile →
Orexigenic Action of Peripheral Ghrelin Is Mediated by Neuropeptide Y and Agouti-Related Protein

2004 525 citations Drew T. Weingarth, Zhu Shen et al. Endocrinology profile →

Peers

Countries citing papers authored by Douglas J. MacNeil

Since Specialization

Citations

This map shows the geographic impact of Douglas J. MacNeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. MacNeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. MacNeil more than expected).

Fields of papers citing papers by Douglas J. MacNeil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. MacNeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. MacNeil. The network helps show where Douglas J. MacNeil may publish in the future.

Co-authorship network of co-authors of Douglas J. MacNeil

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. MacNeil. A scholar is included among the top collaborators of Douglas J. MacNeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. MacNeil. Douglas J. MacNeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Miniaturized Homogenous Assay of Mitochondrial Membrane Potential 2011 ·Assay and Drug Development Technologies ·Aurawan Vongs,Kelli Solly,László Kiss,Douglas J. MacNeil,Charles Rosenblum	3
2	In Vivo Optical Imaging of LacZ Expression Using lacZ Transgenic Mice 2009 ·Assay and Drug Development Technologies ·Guo‐Jun Zhang,Tsing‐Bau Chen,Brett Connolly,Shu-An Lin,Richard Hargreaves,Amy Vanko,Bohumil Bednář,Douglas J. MacNeil,Cyrille Sur,David L. Williams	7
3	Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice 2009 ·European Journal of Pharmacology ·Masahiko Ito,Akane Ishihara,Akira Gomori,Shinichiro Egashira,Hiroko Matsushita,Satoshi Mashiko,Junko Itô,Makoto Ito,(unknown),Yuji Haga,Hisashi Iwaasa,Takao Suzuki,Norikazu Ohtake,Minoru Moriya,Nagaaki Sato,Douglas J. MacNeil,Norihiro Takenaga,Shigeru Tokita,Akio Kanatani	18
4	MCH receptor peptide agonists and antagonists 2009 ·Peptides ·Douglas J. MacNeil,Maria A. Bednarek	7
5	Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice 2009 ·European Journal of Pharmacology ·Ryuichi Moriya,Toru Fujikawa,Junko Itô,Takashi Shirakura,Hiroyasu Hirose,Jun Suzuki,Takahiro Fukuroda,Douglas J. MacNeil,Akio Kanatani	19
6	2006 ·Folia Pharmacologica Japonica ·Akio Kanatani,Akane Ishihara,Hisashi Iwaasa,Douglas J. MacNeil,Takehiro Fukami	2
7	Antiobesity Effect of a Melanin-Concentrating Hormone 1 Receptor Antagonist in Diet-Induced Obese Mice 2005 ·Endocrinology ·Satoshi Mashiko,Akane Ishihara,Akira Gomori,Ryuichi Moriya,Makoto Ito,Hisashi Iwaasa,Masao Matsuda,Yue Feng,Zhu Shen,Donald J. Marsh,Maria A. Bednarek,Douglas J. MacNeil,Akio Kanatani	58
8	Diet Induction of Monocyte Chemoattractant Protein‐1 and its Impact on Obesity 2005 ·Obesity Research ·Airu Chen,(unknown),Chunsheng Zhang,John R. Lamb,Hongyue Dai,Drew T. Weingarth,John S. Mudgett,Howard Chen,Douglas J. MacNeil,Marc L. Reitman,Su Qian	181
9	Expression, refolding, and purification of recombinant human phosphodiesterase 3B: definition of the N-terminus of the catalytic core 2004 ·Protein Expression and Purification ·Jeffrey P. Varnerin,Caroline Chung,Sangita B. Patel,Giovanna Scapin,Emma R. Parmee,Nancy R. Morin,Douglas J. MacNeil,Doris Cully,Lex H.T. Van der Ploeg,Michael R. Tota	7
10	Peripheral and Central Administration of a Selective Neuropeptide Y Y1 Receptor Antagonist Suppresses Ethanol Intake by C57BL/6J Mice 2004 ·Alcoholism Clinical and Experimental Research ·Dennis R. Sparta,Jon R. Fee,Dayna M. Hayes,Darin J. Knapp,Douglas J. MacNeil,Todd E. Thiele	29
11	Chronic administration of nalmefene leads to increased food intake and body weight gain in mice 2004 ·European Journal of Pharmacology ·Richard Z. Chen,Ruey-Ruey C. Huang,Chun-Pyn Shen,Douglas J. MacNeil,Tung M. Fong	9
12	Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice 2004 ·Brain Research ·Richard Z. Chen,Ruey-Ruey C. Huang,Chun-Pyn Shen,Douglas J. MacNeil,Tung M. Fong	53
13	Homology-Based Cloning Methods: Identification of the NPY Y2, Y4, and Y6 Receptors 2003 ·Humana Press eBooks ·Douglas J. MacNeil,David H. Weinberg	1
14	Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion ofd-Trp³⁴NPY 2003 ·Endocrinology ·Satoshi Mashiko,Akane Ishihara,Hisashi Iwaasa,Hideki Sano,(unknown),Junko Itô,Mariko Yumoto,(unknown),Jun Suzuki,Takahiro Fukuroda,Makoto Jitsuoka,Nancy R. Morin,Douglas J. MacNeil,Lex H.T. Van der Ploeg,Masaki Ihara,Takehiro Fukami,Akio Kanatani	51
15	Synthesis and Biological Evaluation in Vitro of a Selective, High Potency Peptide Agonist of Human Melanin-concentrating Hormone Action at Human Melanin-concentrating Hormone Receptor 1 2002 ·Journal of Biological Chemistry ·Maria A. Bednarek,Carina P. Tan,Donna L. Hreniuk,Oksana Palyha,Douglas J. MacNeil,(unknown),Andrew D. Howard,Scott D. Feighner	25
16	Insights about the biosynthesis of the avermectin deoxysugar L-oleandrose through heterologous expression of Streptomyces avermitilis deoxysugar genes in Streptomyces lividans 2001 ·Chemistry & Biology ·Sven‐Eric Wohlert,(unknown),(unknown),Leonid Fonstein,James Occi,Keith M. Gewain,Douglas J. MacNeil,C. Richard Hutchinson	50
17	L-152,804: Orally Active and Selective Neuropeptide Y Y5 Receptor Antagonist 2000 ·Biochemical and Biophysical Research Communications ·Akio Kanatani,Akane Ishihara,Hisashi Iwaasa,Kayo Nakamura,Osamu Okamoto,(unknown),Junko Itô,Takahiro Fukuroda,Douglas J. MacNeil,Lex H.T. Van der Ploeg,Yasuyuki Ishii,Takayoshi Okabe,Takehiro Fukami,Masaki Ihara	110
18	Molecular analysis of a new splice variant of the human melanocortin‐1 receptor 1999 ·FEBS Letters ·Carina P. Tan,Karen K. McKee,David H. Weinberg,Tanya MacNeil,Oksana Palyha,Scott D. Feighner,Donna L. Hreniuk,Lex H.T. Van der Ploeg,Douglas J. MacNeil,Andrew D. Howard	44
19	Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius 1998 ·Nature Biotechnology ·Krishnamurthy Madduri,Jonathan Kennedy,(unknown),(unknown),(unknown),(unknown),(unknown),Keith M. Gewain,James Occi,Douglas J. MacNeil,C. Richard Hutchinson	108
20	Insertion of Transposon Tn5seq1 into G+C-rich DNA of Streptomyces avermitilis: Generation of 8-, 9-, and 10-bp Duplications 1993 ·Plasmid ·James Occi,Patrice H. Gibbons,Emily Wong,Douglas J. MacNeil	1

About Douglas J. MacNeil

Douglas J. MacNeil is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Nutrition and Dietetics, having authored 81 papers that have together received 5.8k indexed citations. Recurring topics across this work include Regulation of Appetite and Obesity (31 papers), Neuropeptides and Animal Physiology (22 papers) and Receptor Mechanisms and Signaling (16 papers). The work is most often cited by research in Endocrine and Autonomic Systems (2.6k citations), Nutrition and Dietetics (1.1k citations) and Pharmacology (1.1k citations). Douglas J. MacNeil has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include Tanya MacNeil, Xiao-Ming Guan, L. H. T. Van der Ploeg, Hong Yu, Prashant Trivedi, Keith M. Gewain, Winston J. Brill, Carolyn L. Ruby, Patrice H. Gibbons and Gabe Dezeny. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact